Alaa Aziz, Desiree R. Czapski, Ravi Ramkissoon, Md Sabid Ahamed, Sarah Al-Noubani, Andrew J. Mier, Oreoluwa Adeleke, Sharel Cornelius, Saiful Chowdhury, Frank W. Foss Jr, Joseph A. Buonomo, Ghader Bashiri and Kayunta L. Johnson-Winters*,
{"title":"Kinetic Characterization of F420-Dependent Sugar-6-Phosphate Dehydrogenase from Cryptosporangium arvum","authors":"Alaa Aziz, Desiree R. Czapski, Ravi Ramkissoon, Md Sabid Ahamed, Sarah Al-Noubani, Andrew J. Mier, Oreoluwa Adeleke, Sharel Cornelius, Saiful Chowdhury, Frank W. Foss Jr, Joseph A. Buonomo, Ghader Bashiri and Kayunta L. Johnson-Winters*, ","doi":"10.1021/acsbiomedchemau.5c00085","DOIUrl":null,"url":null,"abstract":"<p ><i>F</i><sub>420</sub>-dependent glucose-6-phosphate dehydrogenase (FGD) catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-phosphogluconolactone (6PG). Recent phylogenetic analyses have identified a new subclass of these enzymes, <i>F</i><sub>420</sub>-dependent sugar-6-phosphate dehydrogenases (FSDs), which act on a broader range of 6-phosphate sugars, including fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P). One such enzyme from <i>Cryptosporangium arvum</i> (<i>Cryar</i>-FGD) was characterized by using binding assays and kinetic analyses, nuclear magnetic resonance (NMR), and mass spectrometry. Results showed strong binding affinities for all substrates. Steady-state kinetic analysis revealed that G6P has the highest catalytic efficiency, with a <i>k</i><sub>cat(app)</sub> of 6.4 ± 0.2 s<sup>–1</sup>, compared to 1.4 ± 0.1 s<sup>–1</sup> for F6P and 0.32 ± 0.02 s<sup>–1</sup> for M6P. Pre steady-state spectral features for the G6P reaction resembled those of <i>Mycobacterium tuberculosis</i> FGD. While the F6P reaction displayed distinct spectral features, <i>F</i><sub>420</sub> reduction was still observed. In contrast, the spectra for the M6P reaction were markedly different from those of G6P and F6P. Across all substrates, no catalytic intermediates were detected, and hydride transfer was not rate-limiting. As with G6P, the reaction with F6P also produced 6PG. Notably, NMR data showed that F6P was isomerized to G6P, suggesting isomerase activity. In contrast, M6P induced only spectral shifts with no evidence of isomerization or 6PG formation. However, mass spectrometry confirmed oxidized products for all three sugars, each with a mass of 299.0 ± 0.1. Collectively, these findings reveal that <i>Cryar</i>-FGD exhibits both dehydrogenase and isomerase activity, uncovering a newly identified dual enzymatic function and establishing its role as a multifunctional enzyme.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"726–737"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00085","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.5c00085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
F420-dependent glucose-6-phosphate dehydrogenase (FGD) catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-phosphogluconolactone (6PG). Recent phylogenetic analyses have identified a new subclass of these enzymes, F420-dependent sugar-6-phosphate dehydrogenases (FSDs), which act on a broader range of 6-phosphate sugars, including fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P). One such enzyme from Cryptosporangium arvum (Cryar-FGD) was characterized by using binding assays and kinetic analyses, nuclear magnetic resonance (NMR), and mass spectrometry. Results showed strong binding affinities for all substrates. Steady-state kinetic analysis revealed that G6P has the highest catalytic efficiency, with a kcat(app) of 6.4 ± 0.2 s–1, compared to 1.4 ± 0.1 s–1 for F6P and 0.32 ± 0.02 s–1 for M6P. Pre steady-state spectral features for the G6P reaction resembled those of Mycobacterium tuberculosis FGD. While the F6P reaction displayed distinct spectral features, F420 reduction was still observed. In contrast, the spectra for the M6P reaction were markedly different from those of G6P and F6P. Across all substrates, no catalytic intermediates were detected, and hydride transfer was not rate-limiting. As with G6P, the reaction with F6P also produced 6PG. Notably, NMR data showed that F6P was isomerized to G6P, suggesting isomerase activity. In contrast, M6P induced only spectral shifts with no evidence of isomerization or 6PG formation. However, mass spectrometry confirmed oxidized products for all three sugars, each with a mass of 299.0 ± 0.1. Collectively, these findings reveal that Cryar-FGD exhibits both dehydrogenase and isomerase activity, uncovering a newly identified dual enzymatic function and establishing its role as a multifunctional enzyme.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.